{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:45:01Z","timestamp":1781685901018,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.mehy.2011.07.049","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T03:25:42Z","timestamp":1316057142000},"page":"834-836","source":"Crossref","is-referenced-by-count":14,"title":["Novel genetic biomarkers for susceptibility to oral submucous fibrosis: Cytochrome P450 3A"],"prefix":"10.1016","volume":"77","author":[{"given":"Ning","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canhua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchun","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2011.07.049_b0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0528.1985.tb00468.x","article-title":"Malignant transformation rate in oral submucous fibrosis over a 17-year period","volume":"13","author":"Murti","year":"1985","journal-title":"Community Dent Oral Epidemiol"},{"key":"10.1016\/j.mehy.2011.07.049_b0010","first-page":"603","article-title":"Oral submucous fibrosis: a review","volume":"18","author":"Pindorg","year":"1989","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.mehy.2011.07.049_b0015","series-title":"Betel and Miang: vanishing Thai habits","author":"Reichart","year":"2005"},{"issue":"6","key":"10.1016\/j.mehy.2011.07.049_b0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3851\/IMP1652","article-title":"Clinical perspective on antiretroviral drug\u2013drug interactions with the non-nucleoside reverse transcriptase inhibitor etravirine","volume":"15","author":"Kakuda","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.mehy.2011.07.049_b0025","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s11095-006-0277-7","article-title":"CYP induction-mediated drug interactions: in vitro assessment and clinical implications","volume":"23","author":"Lin","year":"2006","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.mehy.2011.07.049_b0030","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1055-9965.EPI-07-2908","article-title":"Discovery of novel biomarkers in oral submucous fibrosis by microarray analysis","volume":"17","author":"Li","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.mehy.2011.07.049_b0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00008571-200203000-00006","article-title":"Common allelic variants of cytochrome P450 3A4 and their prevalence in different populations","volume":"12","author":"Lamba","year":"2002","journal-title":"Pharmacogenetics"},{"issue":"9","key":"10.1016\/j.mehy.2011.07.049_b0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2165\/10895940-000000000-00000","article-title":"Clinical pharmacokinetics and pharmacodynamics of etravirine","volume":"48","author":"Sch\u00f6ller-Gy\u00fcre","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.mehy.2011.07.049_b0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00008571-200007000-00005","article-title":"Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans","volume":"10","author":"Paulussen","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.mehy.2011.07.049_b0050","doi-asserted-by":"crossref","first-page":"12536","DOI":"10.1021\/bi980895g","article-title":"Structure\u2013function relationships of human liver cytochrome P450 3A: Aflatoxin B1 metabolism as a probe","volume":"37","author":"Wang","year":"1998","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.mehy.2011.07.049_b0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/mol.62.1.162","article-title":"Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism","volume":"62","author":"Lin","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2011.07.049_b0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.mehy.2011.07.049_b0065","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425255.2.4.629","article-title":"Luminogenic cytochrome P450 assays","volume":"2","author":"Cali","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711003677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711003677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T22:25:09Z","timestamp":1543530309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987711003677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0306987711003677"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2011.07.049","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}